16 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Identifying Interactions that Determine Fragment Binding at Protein Hotspots.
Cambridge Crystallographic Data Centre
Design, synthesis and biological evaluation of imidazo[2,1-b]thiazole and benzo[d]imidazo[2,1-b]thiazole derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
Birla Institute of Technology
Synthesis, in vitro antimycobacterial evaluation and docking studies of some new 5,6,7,8-tetrahydropyrido[4',3':4,5]thieno[2,3-d]pyrimidin-4(3H)-one schiff bases.
University College of Pharmaceutical Sciences
Development of novel tetrahydrothieno[2,3-c]pyridine-3-carboxamide based Mycobacterium tuberculosis pantothenate synthetase inhibitors: molecular hybridization from known antimycobacterial leads.
Birla Institute of Technology
Reaction intermediate analogues as bisubstrate inhibitors of pantothenate synthetase.
Soochow University
Development of 3-phenyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine derivatives as novel Mycobacterium tuberculosis pantothenate synthetase inhibitors.
Birla Institute of Technology
ATP-binding site of bacterial enzymes as a target for antibacterial drug design.
University of Ljubljana
5-tert-butyl-N-pyrazol-4-yl-4,5,6,7-tetrahydrobenzo[d]isoxazole-3-carboxamide derivatives as novel potent inhibitors of Mycobacterium tuberculosis pantothenate synthetase: initiating a quest for new antitubercular drugs.
University of Illinois At Chicago
A discovery of novel Mycobacterium tuberculosis pantothenate synthetase inhibitors based on the molecular mechanism of actinomycin D inhibition.
Chinese Academy of Medical Sciences and Peking Union Medical College
Emerging impact of triazoles as anti-tubercular agent.
Barauni (A Constituent Unit of Lalit Narayan Mithila University)
Identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
Birla Institute of Technology & Science-Pilani
Triazole derivatives and their anti-tubercular activity.
Wuhan University of Science and Technology
Recent advances of pyrazole-containing derivatives as anti-tubercular agents.
Wuhan University of Science and Technology